Literature DB >> 1911736

Structural and functional brain imaging in schizophrenia.

J M Cleghorn1, R B Zipursky, S J List.   

Abstract

We present an evaluation of the contribution of structural and functional brain imaging to our understanding of schizophrenia. Methodological influences on the validity of the data generated by these new technologies include problems with measurement and clinical and anatomic heterogeneity. These considerations greatly affect the interpretation of the data generated by these technologies. Work in these fields to date, however, has produced strong evidence which suggests that schizophrenia is a disease which involves abnormalities in the structure and function of many brain areas. Structural brain imaging studies of schizophrenia using computed tomography (CT) and magnetic resonance imaging (MRI) are reviewed and their contribution to current theories of the pathogenesis of schizophrenia are discussed. Positron emission tomography (PET) studies of brain metabolic activity and dopamine receptor binding in schizophrenia are summarized and the critical questions raised by these studies are outlined. Future studies in these fields have the potential to yield critical insights into the pathophysiology of schizophrenia; new directions for studies of schizophrenia using these technologies are identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911736      PMCID: PMC1188296     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  152 in total

1.  Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics.

Authors:  J L Martinot; J D Huret; P Peron-Magnan; B M Mazoyer; J C Baron; V Caillard; A Syrota; H Loo
Journal:  Psychiatry Res       Date:  1989-09       Impact factor: 3.222

2.  Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

Authors:  P Seeman; H B Niznik; H C Guan; G Booth; C Ulpian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.

Authors:  J C Baron; J L Martinot; H Cambon; J P Boulenger; M F Poirier; V Caillard; J Blin; J D Huret; C Loc'h; B Maziere
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Striatal dopamine D2 receptors in tardive dyskinesia: PET study.

Authors:  J Blin; J C Baron; H Cambon; A M Bonnet; B Dubois; C Loc'h; B Mazière; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

5.  Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.

Authors:  M M Bahn; S C Huang; R A Hawkins; N Satyamurthy; J M Hoffman; J R Barrio; J C Mazziotta; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1989-12       Impact factor: 6.200

6.  Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.

Authors:  A Wolkin; F Barouche; A P Wolf; J Rotrosen; J S Fowler; C Y Shiue; T B Cooper; J D Brodie
Journal:  Am J Psychiatry       Date:  1989-07       Impact factor: 18.112

7.  3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.

Authors:  J Kornhuber; P Riederer; G P Reynolds; H Beckmann; K Jellinger; E Gabriel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.

Authors:  L Farde; L Eriksson; G Blomquist; C Halldin
Journal:  J Cereb Blood Flow Metab       Date:  1989-10       Impact factor: 6.200

9.  Striatal and frontal cortex binding of 11-C-labelled clozapine visualized by positron emission tomography (PET) in drug-free schizophrenics and healthy volunteers.

Authors:  T Lundberg; L H Lindström; P Hartvig; S A Eckernâs; B Ekblom; H Lundqvist; K J Fasth; P Gullberg; B Långström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 10.  Positron emission tomography in psychiatry.

Authors:  F A Wiesel
Journal:  Psychiatr Dev       Date:  1989
View more
  4 in total

Review 1.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

Review 2.  Schizophrenia: D4 receptor elevation. What does it mean?

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

Review 3.  Are mental diseases brain diseases? The contribution of neuropathology to understanding of schizophrenic psychoses.

Authors:  M B Knable; D R Weinberger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

4.  Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study.

Authors:  Pauline Soh; Balaji Narayanan; Sabin Khadka; Vince D Calhoun; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz; Godfrey D Pearlson
Journal:  Front Psychiatry       Date:  2015-11-09       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.